Switzerland · Venture startup

Who invested in Ymmunobio

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round
VentureNov 2024
Investors
1
See who backed them

The rounds

  1. Nov 2024
    VentureAmount undisclosed

    Source recorded

Founders and team

From Ymmunobio's own website: 1 on the team.

  • Martin ZuzuloChief Operating Officer

Everyone who backed them

InnosuisseGovernment1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about Ymmunobio

Who invested in Ymmunobio?

Ymmunobio's investors include Innosuisse.

How much has Ymmunobio raised?

Ymmunobio has raised 1 round since 2024, none with a disclosed amount.

When did Ymmunobio last raise?

Ymmunobio's most recent round was a Venture in Nov 2024.

Who backed Ymmunobio first?

Ymmunobio's first round on record, in Nov 2024, was backed by Innosuisse.

What stage is Ymmunobio at?

Ymmunobio's latest named round is a Venture, in Nov 2024.

Where is Ymmunobio based?

Ymmunobio is based in Switzerland.

Companies like Ymmunobio

In the same sector, and raised in the last eighteen months.

Nouscom$191M · Oct 2026ADC Therapeutics$646M · Oct 2026AnaCardio$89M · Oct 2026NovaGo Therapeutics$40M · Sept 2026Prevision Medicine$5.4M · Sept 2026Medyria$6.7M · Jul 2026

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.

Open the investor searchOr these rounds in the app